CryoValve® SG Aortic Human Heart Valve Combination Study

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

May 31, 2011

Study Completion Date

February 29, 2012

Conditions
Aortic Valve StenosisAortic Valve Insufficiency
Interventions
PROCEDURE

Echocardiogram

A prospective follow-up Study Echocardiogram will be performed, as applicable, for those subjects who do not have echo data as of January 1, 2009.

Trial Locations (9)

46202

Indiana University, Indianapolis

48109

C.S. Mott Children's Hospital, Ann Arbor

55905

Mayo Clinic, Rochester

64108

The Children's Mercy Hospital, Kansas City

73104

University of Oklahoma Health Sciences Center, Oklahoma City

80045

The Children's Hsopital, Aurora

85006

Arizona Pediatric Cardiology Consultants, Phoenix

90048

Cedars-Sinai Medical Center, Los Angeles

92123

Rady Children's Hospital, San Diego

Sponsors

Lead Sponsor

All Listed Sponsors
lead

CryoLife, Inc.

INDUSTRY

NCT01236469 - CryoValve® SG Aortic Human Heart Valve Combination Study | Biotech Hunter | Biotech Hunter